Panacea Index Logo

Command Palette

Search for a command to run...

Vitamin D in European children-statement from the European Academy of Paediatrics (EAP).

European journal of pediatrics
June 1, 2017
Zachi Grossman et al. (7 authors)
Journal ArticlePractice GuidelineHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the role of vitamin D in calcium and phosphate metabolism and its importance for bone health, particularly in preventing rickets and addressing deficiency in high-risk groups.

Results Summary

The study affirmed that vitamin D is essential for bone health and preventing rickets, with supplementation recommended for infants up to 1 year (400 IU/day). However, routine screening for deficiency in healthy children is unjustified due to unclear definitions of deficiency and inter-assay variability.

Population

Healthy and high-risk children (e.g., darker pigmented skin, reduced sun exposure areas, and other disorders), particularly infants up to 1 year.

Effective Dosage

400 IU/day (oral supplementation for infants up to 1 year).

Duration

Not specified beyond infancy (up to 1 year).

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Vitamin D supplementation
neutral
bone health
-
-
is essential for the maintenance of
#1
Vitamin D supplementation
decrease
rickets
infants
-
is universally accepted to prevent
#2
oral supplementation of 400 IU/day of vitamin D
neutral
-
All infants up to 1 year of age
400 IU/day
should be received by
#3
Abstract

Vitamin D is synthesized in human skin upon sun exposure and is also a nutrient. It regulates calcium and phosphate metabolism and is essential for the maintenance of bone health. Vitamin D supplementation during infancy, in order to prevent rickets, is universally accepted. Many human cell types carry vitamin D receptor, this being a drive for conducting studies on the possible association between vitamin D status and other diseases. Studies have affirmed that a considerable number of healthy European children may be vitamin D deficient, especially in high-risk groups (darker pigmented skin, living in areas with reduced sun exposure and other disorders). However, the definition of deficiency is unclear due to inter assay differences and due to a lack of consensus as to what is an "adequate" 25(OH)D level. Therefore, there is no justification for routine screening for vitamin D deficiency in healthy children. An evaluation of vitamin D status is justified in children belonging to high-risk groups. All infants up to 1 year of age should receive an oral supplementation of 400 IU/day of vitamin D. Beyond this age, seasonal variation of sunlight should be taken into account when considering a national policy of supplementation or fortification.

Medical Subject Headings (MeSH)
ChildChild, PreschoolDietary SupplementsEuropeHumansInfantRecommended Dietary AllowancesVitamin DVitamin D DeficiencyVitamins
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations49
Citations/Year6.1
Relative Citation Ratio2.87
NIH Percentile84%
Research Impact Scores
APT Score0.95
Weight Score2.04
Normalized Score0.69
Related Supplements
Vitamin D in European children-statement from the European A... | Panacea Index